Skip to content

Multisite Virtual Reality Intervention for Speech Anxiety

Multisite Virtual Reality Intervention for Speech Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06593847
Acronym
ETC2
Enrollment
1542
Registered
2024-09-19
Start date
2024-10-08
Completion date
2025-07-23
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Public Speaking, Speech Anxiety

Brief summary

Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.

Detailed description

The goal of this multicenter clinical trial is to examine predictors of VR exposure therapy outcomes for college students with public speaking anxiety following a positive or negative mood induction. The overarching aim of the present study is to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism. State affect is manipulated at an experimental level with affect induction procedures; trait positive affectivity is measured at baseline. The study involves three phases: (1) initial screening, (2) in-person assessment and brief exposure intervention for a subset of participants with elevated public speaking anxiety, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on a public speaking anxiety scale will be assigned to a positive or negative mood induction condition prior to undergoing VR-based exposure therapy. Public speaking and social anxiety outcomes are measured immediately post-intervention and one week later. The one-week follow-up assessment represents the primary outcome.

Interventions

BEHAVIORALSingle-session VR exposure intervention

VR exposure is the only intervention, but the VR intervention is conducted following either positive or negative mood induction.

Sponsors

University of Texas at Austin
CollaboratorOTHER
Curtin University
CollaboratorOTHER
Erasmus University Rotterdam
CollaboratorOTHER
National University of Singapore
CollaboratorOTHER
Southern Illinois University
CollaboratorOTHER
Tufts University
CollaboratorOTHER
The University of New South Wales
CollaboratorOTHER
University of Western Sydney
CollaboratorOTHER
University of Arizona
CollaboratorOTHER
The University of Hong Kong
CollaboratorOTHER
Philipps Universität Marburg
CollaboratorUNKNOWN
Albright College
CollaboratorUNKNOWN
Utrecht University
CollaboratorOTHER
Boston University Charles River Campus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Participants are blind to the study hypothesis and outcomes are assessed by participant self-report.

Intervention model description

Single session VR-based exposure therapy

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Self-report of 18 - 70 years of age * Current student at a participating University * Ability to read English to provide informed consent * Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet). * For Phase 2: speech anxiety scale score of ≥ 18 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS)

Exclusion criteria

* Previous participation (i.e., no participant may take the survey more than once).

Design outcomes

Primary

MeasureTime frameDescription
Public Speaking AnxietyOne week follow-up assessmentAssessed using the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS). Scores range from 6 to 30, with higher scores associated with higher public speaking anxiety.

Secondary

MeasureTime frameDescription
ValenceOne week follow-up assessmentSelf-report measure of how participant feels about having to give a speech
Assessed using the Social Phobia Inventory (SPIN)One week follow-up assessmentAssessed using the Social Phobia Inventory (SPIN). Scores range from 0-68, with higher scores indicating greater social phobia.
Public Speaking AnxietyPost-treatment assessment immediately after the interventionAssessed using the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS). Scores range from 6 to 30, with higher scores associated with higher public speaking anxiety.

Countries

Australia, China, Germany, Netherlands, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026